← All trials
NCT04499573
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 27, 2020
- Primary completion
- Dec 31, 2022
- Completion date
- Dec 31, 2025
- First posted
- Aug 5, 2020
- Last posted
- Dec 1, 2020
- Enrollment
- 30
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyLead sponsor
- Government of RussiaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.